Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
To understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera (1–11 days post-admission) and 92 convalescent sera (56 with COVID-19-assoc...
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
مؤلفون آخرون: | |
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer Nature
2023
|
_version_ | 1826311929138774016 |
---|---|
author | Michael, BD Dunai, C Needham, EJ Tharmaratnam, K Williams, R Huang, Y Boardman, SA Clark, JJ Sharma, P Subramaniam, K Wood, GK Collie, C Digby, R Ren, A Norton, E Leibowitz, M Ebrahimi, S Fower, A Fox, H Tato, E Ellul, MA Sunderland, G Held, M Hetherington, C Egbe, FN Palmos, A Stirrups, K Grundmann, A Chiollaz, A-C Sanchez, J-C Stewart, JP Griffiths, M Solomon, T Breen, G Coles, AJ Kingston, N Bradley, JR Chinnery, PF Cavanagh, J Irani, SR Vincent, A Baillie, JK Openshaw, PJ Semple, MG Taams, LS Menon, DK Horby, PW Klenerman, P Merson, L Sigfrid, L Stuart, D Lee, J Plotkin, D Carson, G Duff, E Miller, K Husain, M Harrison, PJ Jezzard, P Smith, S |
author2 | ISARIC4C Investigators |
author_facet | ISARIC4C Investigators Michael, BD Dunai, C Needham, EJ Tharmaratnam, K Williams, R Huang, Y Boardman, SA Clark, JJ Sharma, P Subramaniam, K Wood, GK Collie, C Digby, R Ren, A Norton, E Leibowitz, M Ebrahimi, S Fower, A Fox, H Tato, E Ellul, MA Sunderland, G Held, M Hetherington, C Egbe, FN Palmos, A Stirrups, K Grundmann, A Chiollaz, A-C Sanchez, J-C Stewart, JP Griffiths, M Solomon, T Breen, G Coles, AJ Kingston, N Bradley, JR Chinnery, PF Cavanagh, J Irani, SR Vincent, A Baillie, JK Openshaw, PJ Semple, MG Taams, LS Menon, DK Horby, PW Klenerman, P Merson, L Sigfrid, L Stuart, D Lee, J Plotkin, D Carson, G Duff, E Miller, K Husain, M Harrison, PJ Jezzard, P Smith, S |
author_sort | Michael, BD |
collection | OXFORD |
description | To understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera (1–11 days post-admission) and 92 convalescent sera (56 with COVID-19-associated neurological diagnoses). Here we show that compared to 60 uninfected controls, tTau, GFAP, NfL, and UCH-L1 are increased with COVID-19 infection at acute timepoints and NfL and GFAP are significantly higher in participants with neurological complications. Inflammatory mediators (IL-6, IL-12p40, HGF, M-CSF, CCL2, and IL-1RA) are associated with both altered consciousness and markers of brain injury. Autoantibodies are more common in COVID-19 than controls and some (including against MYL7, UCH-L1, and GRIN3B) are more frequent with altered consciousness. Additionally, convalescent participants with neurological complications show elevated GFAP and NfL, unrelated to attenuated systemic inflammatory mediators and to autoantibody responses. Overall, neurological complications of COVID-19 are associated with evidence of neuroglial injury in both acute and late disease and these correlate with dysregulated innate and adaptive immune responses acutely. |
first_indexed | 2024-03-07T08:18:32Z |
format | Journal article |
id | oxford-uuid:52dc98d7-826c-4627-965f-019d4784b670 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T08:18:32Z |
publishDate | 2023 |
publisher | Springer Nature |
record_format | dspace |
spelling | oxford-uuid:52dc98d7-826c-4627-965f-019d4784b6702024-01-16T11:48:48ZPara-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responsesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:52dc98d7-826c-4627-965f-019d4784b670EnglishSymplectic ElementsSpringer Nature2023Michael, BDDunai, CNeedham, EJTharmaratnam, KWilliams, RHuang, YBoardman, SAClark, JJSharma, PSubramaniam, KWood, GKCollie, CDigby, RRen, ANorton, ELeibowitz, MEbrahimi, SFower, AFox, HTato, EEllul, MASunderland, GHeld, MHetherington, CEgbe, FNPalmos, AStirrups, KGrundmann, AChiollaz, A-CSanchez, J-CStewart, JPGriffiths, MSolomon, TBreen, GColes, AJKingston, NBradley, JRChinnery, PFCavanagh, JIrani, SRVincent, ABaillie, JKOpenshaw, PJSemple, MGTaams, LSMenon, DKHorby, PWKlenerman, PMerson, LSigfrid, LStuart, DLee, JPlotkin, DCarson, GDuff, EMiller, KHusain, MHarrison, PJJezzard, PSmith, SISARIC4C InvestigatorsCOVID-CNS ConsortiumTo understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera (1–11 days post-admission) and 92 convalescent sera (56 with COVID-19-associated neurological diagnoses). Here we show that compared to 60 uninfected controls, tTau, GFAP, NfL, and UCH-L1 are increased with COVID-19 infection at acute timepoints and NfL and GFAP are significantly higher in participants with neurological complications. Inflammatory mediators (IL-6, IL-12p40, HGF, M-CSF, CCL2, and IL-1RA) are associated with both altered consciousness and markers of brain injury. Autoantibodies are more common in COVID-19 than controls and some (including against MYL7, UCH-L1, and GRIN3B) are more frequent with altered consciousness. Additionally, convalescent participants with neurological complications show elevated GFAP and NfL, unrelated to attenuated systemic inflammatory mediators and to autoantibody responses. Overall, neurological complications of COVID-19 are associated with evidence of neuroglial injury in both acute and late disease and these correlate with dysregulated innate and adaptive immune responses acutely. |
spellingShingle | Michael, BD Dunai, C Needham, EJ Tharmaratnam, K Williams, R Huang, Y Boardman, SA Clark, JJ Sharma, P Subramaniam, K Wood, GK Collie, C Digby, R Ren, A Norton, E Leibowitz, M Ebrahimi, S Fower, A Fox, H Tato, E Ellul, MA Sunderland, G Held, M Hetherington, C Egbe, FN Palmos, A Stirrups, K Grundmann, A Chiollaz, A-C Sanchez, J-C Stewart, JP Griffiths, M Solomon, T Breen, G Coles, AJ Kingston, N Bradley, JR Chinnery, PF Cavanagh, J Irani, SR Vincent, A Baillie, JK Openshaw, PJ Semple, MG Taams, LS Menon, DK Horby, PW Klenerman, P Merson, L Sigfrid, L Stuart, D Lee, J Plotkin, D Carson, G Duff, E Miller, K Husain, M Harrison, PJ Jezzard, P Smith, S Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title | Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title_full | Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title_fullStr | Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title_full_unstemmed | Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title_short | Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses |
title_sort | para infectious brain injury in covid 19 persists at follow up despite attenuated cytokine and autoantibody responses |
work_keys_str_mv | AT michaelbd parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT dunaic parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT needhamej parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT tharmaratnamk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT williamsr parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT huangy parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT boardmansa parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT clarkjj parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT sharmap parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT subramaniamk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT woodgk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT colliec parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT digbyr parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT rena parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT nortone parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT leibowitzm parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT ebrahimis parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT fowera parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT foxh parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT tatoe parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT ellulma parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT sunderlandg parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT heldm parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT hetheringtonc parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT egbefn parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT palmosa parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT stirrupsk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT grundmanna parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT chiollazac parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT sanchezjc parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT stewartjp parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT griffithsm parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT solomont parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT breeng parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT colesaj parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT kingstonn parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT bradleyjr parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT chinnerypf parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT cavanaghj parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT iranisr parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT vincenta parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT bailliejk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT openshawpj parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT semplemg parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT taamsls parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT menondk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT horbypw parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT klenermanp parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT mersonl parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT sigfridl parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT stuartd parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT leej parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT plotkind parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT carsong parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT duffe parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT millerk parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT husainm parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT harrisonpj parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT jezzardp parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses AT smiths parainfectiousbraininjuryincovid19persistsatfollowupdespiteattenuatedcytokineandautoantibodyresponses |